Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy Hugo J. A. AdamsRutger A. J. NievelsteinThomas C. Kwee Review Article Open access 20 October 2015 Pages: 1 - 9
Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review Hugo J. A. AdamsRutger A. J. NievelsteinThomas C. Kwee Review Article Open access 18 November 2015 Pages: 11 - 18
Effect of rituximab on adult Burkitt’s lymphoma: a systematic review and meta-analysis Man NieYu WangWen-Qi Jiang Original Article 01 October 2015 Pages: 19 - 26
Screening for viral hepatitis prior to rituximab chemotherapy A. N. LeonardB. L. LoveC. L. Bennett Original Article 18 September 2015 Pages: 27 - 33
Loss of interleukin-21 leads to atrophic germinal centers in multicentric Castleman’s disease Hidetaka YajimaMotohisa YamamotoHiroki Takahashi Original Article 17 September 2015 Pages: 35 - 40
Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma Yoshikazu UtsuKoji TakaishiHisashi Wakita Original Article 05 October 2015 Pages: 41 - 47
High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma S. AkhtarT. A. M. ElhassanI. Maghfoor Original Article 15 October 2015 Pages: 49 - 54
Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen Sung-Hoon JungJin Seok KimJe-Jung Lee Original Article 15 October 2015 Pages: 55 - 61
Changes in survival rate of multiple myeloma after the introduction of bortezomib: a single institutional experience over 20 years Manabu FujisawaYasuhito SueharaKosei Matsue Original Article 24 October 2015 Pages: 63 - 72
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents? Erica TsangHeather A. Leitch Original Article 10 October 2015 Pages: 73 - 78
Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome Dolly JoshiSeema KorgaonkarBabu Rao Vundinti Original Article 19 October 2015 Pages: 79 - 85
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL Shinichi KakoYu AkahoshiYoshinobu Kanda Original Article 22 September 2015 Pages: 87 - 92
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials Pauline SimonStefan Suciuon behalf of the Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC) Original Article 12 October 2015 Pages: 93 - 103
A randomized clinical trial on the effectiveness of an intervention to treat psychological distress and improve quality of life after autologous stem cell transplantation Annemarie M. J. BraamseB. van MeijelJ. Dekker Original Article Open access 30 September 2015 Pages: 105 - 114
Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies Dominik SchneidawindBirgit FedermannWolfgang A. Bethge Original Article 28 September 2015 Pages: 115 - 124
Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry Jin Seok KimJun Ho JangJong Wook Lee Original Article 29 September 2015 Pages: 125 - 133
The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major Mehran KarimiForoogh ToosiEliezer A. Rachmilewitz Original Article 22 September 2015 Pages: 135 - 139
ACTN1 rod domain mutation associated with congenital macrothrombocytopenia Motoko YasutomiShinji KunishimaYusei Ohshima Original Article 10 October 2015 Pages: 141 - 144
Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma Semra PaydasAli OgulSerkan Gokcay Letter to the Editor 04 September 2015 Pages: 145 - 146
Enigmatic meningitis in a patient with T cell lymphoma Thomas SchneiderIoannis AnagnostopoulosStefan Schwartz Letter to the Editor 11 September 2015 Pages: 147 - 148
A coincidence or a rare occurrence? A case of plasmablastic lymphoma of the small intestines following infliximab treatment for Crohn’s disease Su Wai MaungRonan DesmondHelen Enright Letter to the Editor 12 September 2015 Pages: 149 - 150
Cold antibody autoimmune haemolytic anaemia in a child with diffuse large B cell lymphoma Lena UzunovaC. Elizabeth HookG. Amos Burke Letter to the Editor 14 September 2015 Pages: 151 - 152
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy M. PostorinoL. PupoS. Amadori Letter to the Editor 07 October 2015 Pages: 153 - 154
CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsis Lambros KordelasTanja GromkeDietrich W. Beelen Letter to the Editor 18 September 2015 Pages: 155 - 156
D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation Runhui ZhengBailu XieHuo Tan Letter to the Editor 18 September 2015 Pages: 157 - 159
A case of MYH9 disorders caused by a novel mutation (p.K74E) Takeshi KanematsuNobuaki SuzukiShinji Kunishima Letter to the Editor 17 September 2015 Pages: 161 - 163
A nationwide population-based cross-sectional comparison of hematological malignancies incidences between Taiwan and the United States of America Shang-Ju WuChun-Ju ChiangMei-Shu Lai Letter to the Editor 26 September 2015 Pages: 165 - 167
Acute promyelocytic leukemia following solid organ transplantation Armin RashidiPaul R. ConklingStephen I. Fisher Letter to the Editor 10 October 2015 Pages: 169 - 171